jueves, 5 de junio de 2025

FDA approves darolutamide for metastatic castration-sensitive prostate cancer

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-darolutamide-metastatic-castration-sensitive-prostate-cancer?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario